1 / 17

Measles Vaccination in Epidemic Contexts

Measles Vaccination in Epidemic Contexts. RF Grais, ACK Conlan, MJ Ferrari, C Dubray, A Djibo, F Fermon, M-E Burny, KP Alberti, I Jeanne, BS Hersh, PJ Guerin, ON Bjornstad, BT Grenfell June 1 , 2006. Background. Cases. Place. Year. Length (months). 1. 12+. 6. Kinshasa, DRC.

trilby
Download Presentation

Measles Vaccination in Epidemic Contexts

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Measles Vaccination in Epidemic Contexts RF Grais, ACK Conlan, MJ Ferrari, C Dubray, A Djibo, F Fermon, M-E Burny, KP Alberti, I Jeanne, BS Hersh, PJ Guerin, ON Bjornstad, BT Grenfell June 1, 2006

  2. Background Cases Place Year Length (months) 1 12+ 6 Kinshasa, DRC 17624 2002 Kinshasa, DRC 40857 2005 Niamey, Niger 10880 2003 Adamawa, Nigeria 2505 2004 Ndjamena, Chad 8015 2005

  3. Rationale • Operational guidance for MSF • WHO guidelines (1999) • Spread so fast its always too late • Scarce resources best invested elsewhere • Based on literature review and mathematical models of epidemics in non-African settings

  4. Objectives • Measure the impact of vaccination interventions • Examine: • Timing of interventions in course of epidemic • Age range to vaccinate • Intervention vaccination coverage • Generalize to other settings

  5. Overview of methodology • Estimate effective reproductive ratio • Chain-Binomial/MLE • Ferrari, et al, 2005, Math Biosc, 98(1), 14-26 • Recreate epidemic & simulate interventions • Individual-based model • Niamey, Niger 2003-2004 as a case study • Generalize results • Standard epidemic model with vaccination

  6. 1) Estimating the Effective Reproductive Ratio (R) • Niamey, Niger (2003-2004): 2.8 • Kinshasa, DRC (2005-6): 1.9 • Ndjamena, Chad (2005): 2.5 I I NI I NI I R= avg number secondary cases generated by one case in a partially immune population

  7. 2) Recreating an epidemic, Niamey, Niger 2003-2004: Key Assumptions • Constant • 15 day delay between decision and delivery • 10 day intervention • Vaccine efficiency = 85% • Variable • 2 age ranges for vaccination (standard): • 6m to 59m • 6m to <15y • Interventions: • 2, 3 or 4 months after epidemic starts • vaccination coverage: 30% – 100%

  8. 2) Model Overview: Niamey, Niger • Probability of infection: • age • immune status • vaccination status • location in the city • status of other children • contact decreases with distance • time

  9. 2) Model Overview: Niamey, Niger • Probability of infection: • age • immune status • vaccination status • location in the city • status of other children • contact decreases with distance • time

  10. 2) Model Overview: Niamey, Niger • Probability of infection: • age • immune status • vaccination status • location in the city • status of other children • contact decreases with distance • time

  11. 2) Model Overview: Niamey, Niger • Probability of infection: • age • immune status • vaccination status • location in the city • status of other children • contact decreases with distance • time

  12. 2) Model Overview: Niamey, Niger • Probability of infection: • age • immune status • vaccination status • location in the city • status of other children • contact decreases with distance • time

  13. 2) Proportion cases prevented by intervention coverage and time: 6 to 59m, Niamey, Niger 100 2 months 3 months 90 4 months + 6 months 80 70 60 Proportion of Cases Prevented (%) 50 40 30 20 10 0 30 40 50 60 70 80 90 100 Intervention Coverage (%)

  14. 2) Proportion cases prevented by intervention coverage and time: 6 to 15y, Niamey, Niger 100 90 80 70 60 Proportion of cases prevented(%) 50 40 2 months 3 months 30 4 months 20 10 0 30 40 50 60 70 80 90 100 Intervention Coverage (%)

  15. 3) Generalizing to different scenarios (ex.: 50% coverage, 10 days, 100 000 persons) Proportion reduction in number of cases R Day of intervention

  16. Conclusions • More time than we thought to intervene • 3 Key Factors • Timing • Age range for vaccination • Vaccination coverage objective • Benefit even when late • Up to 8% = 800 cases • Revision of WHO guidelines

  17. Ministries of Health, Niger, Nigeria, Chad, DRC MSF-F and MSF-B in field and Paris WHO Survey teams Study participants Center for Infectious Disease Dynamics CERMES EPIET Acknowledgements

More Related